4D Molecular Therapeutics, Inc. Major Shareholders & Ownership History
| Major Shareholder Name | Reporting Date | Shares Held | Market Value | Change in Shares | Ownership |
|---|---|---|---|---|---|
| BVF INC/IL | 11/14/2025 | 4.63 M | $40.23 M | 0.00% | 8.28% |
| RA CAPITAL MANAGEMENT, L.P. | 11/14/2025 | 4.56 M | $39.65 M | 0.00% | 8.16% |
| GOLDMAN SACHS GROUP INC | 11/14/2025 | 4.13 M | $35.88 M | -0.74% | 7.38% |
| BLACKROCK, INC. | 11/12/2025 | 3.87 M | $33.62 M | -3.53% | 6.92% |
| VANGUARD GROUP INC | 11/07/2025 | 2.58 M | $22.38 M | -5.90% | 4.60% |
| NOVO HOLDINGS A/S | 11/14/2025 | 2.00 M | $17.38 M | 0.00% | 3.58% |
| JANUS HENDERSON GROUP PLC | 11/14/2025 | 1.75 M | $15.24 M | -0.06% | 3.14% |
| FEDERATED HERMES, INC. | 11/03/2025 | 1.59 M | $13.86 M | -4.35% | 2.85% |
| MILLENNIUM MANAGEMENT LLC | 11/14/2025 | 1.15 M | $9.99 M | -22.53% | 2.06% |
| ARMISTICE CAPITAL, LLC | 11/17/2025 | 1.10 M | $9.52 M | 265.33% | 1.96% |
| GEODE CAPITAL MANAGEMENT, LLC | 11/12/2025 | 913.52 K | $7.94 M | -0.55% | 1.63% |
| STATE STREET CORP | 11/14/2025 | 903.77 K | $7.85 M | -6.05% | 1.62% |
| MORGAN STANLEY | 11/14/2025 | 835.91 K | $7.26 M | -9.60% | 1.49% |
| BANK OF AMERICA CORP /DE/ | 11/14/2025 | 819.27 K | $7.12 M | -8.67% | 1.46% |
| ASSENAGON ASSET MANAGEMENT S.A. | 10/07/2025 | 663.66 K | $5.77 M | 2.29% | 1.19% |
| TWO SIGMA ADVISERS, LP | 11/14/2025 | 549.70 K | $4.78 M | -26.06% | 0.98% |
| DEUTSCHE BANK AG\ | 11/13/2025 | 543.33 K | $4.72 M | 139.42% | 0.97% |
| JPMORGAN CHASE & CO | 11/26/2025 | 513.52 K | $4.46 M | -42.17% | 0.92% |
| ARROWMARK COLORADO HOLDINGS LLC | 11/14/2025 | 504.12 K | $4.38 M | -2.04% | 0.90% |
| RAYMOND JAMES FINANCIAL INC | 11/14/2025 | 471.27 K | $4.10 M | 3.47% | 0.84% |
| NORTHERN TRUST CORP | 11/14/2025 | 335.59 K | $2.92 M | 2.01% | 0.60% |
| PEAPOD LANE CAPITAL LLC | 11/10/2025 | 322.08 K | $2.80 M | 1.11% | 0.58% |
| RENAISSANCE TECHNOLOGIES LLC | 11/13/2025 | 313.19 K | $2.72 M | 168.71% | 0.56% |
| CHARLES SCHWAB INVESTMENT MANAGEMENT INC | 11/10/2025 | 305.86 K | $2.66 M | 3.67% | 0.55% |
| TWO SIGMA INVESTMENTS, LP | 11/14/2025 | 273.50 K | $2.38 M | -48.51% | 0.49% |
| PARKMAN HEALTHCARE PARTNERS LLC | 11/14/2025 | 200.00 K | $1.74 M | 100.00% | 0.36% |
| PRIVIUM FUND MANAGEMENT B.V. | 11/04/2025 | 197.46 K | $1.72 M | 0.00% | 0.35% |
| SCHONFELD STRATEGIC ADVISORS LLC | 11/14/2025 | 179.08 K | $1.56 M | 100.00% | 0.32% |
| ADAGE CAPITAL PARTNERS GP, L.L.C. | 11/14/2025 | 175.00 K | $1.52 M | 100.00% | 0.31% |
| ROYAL BANK OF CANADA | 11/14/2025 | 172.11 K | $1.50 M | -0.36% | 0.31% |
| PERIGON WEALTH MANAGEMENT, LLC | 10/17/2025 | 146.13 K | $1.27 M | 0.00% | 0.26% |
| MARSHALL WACE, LLP | 11/13/2025 | 145.91 K | $1.27 M | -43.36% | 0.26% |
| BANK OF NEW YORK MELLON CORP | 11/03/2025 | 141.72 K | $1.23 M | 0.44% | 0.25% |
| WELLINGTON MANAGEMENT GROUP LLP | 11/14/2025 | 135.47 K | $1.18 M | 100.00% | 0.24% |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP | 11/14/2025 | 132.81 K | $1.15 M | 6.42% | 0.24% |
| INVESCO LTD. | 11/13/2025 | 126.58 K | $1.10 M | -9.80% | 0.23% |
| JANE STREET GROUP, LLC | 11/14/2025 | 116.92 K | $1.02 M | -38.59% | 0.21% |
| UBS GROUP AG | 11/13/2025 | 94.90 K | $824.68 K | -1.68% | 0.17% |
| NUVEEN, LLC | 11/12/2025 | 93.92 K | $816.16 K | -6.74% | 0.17% |
| BARCLAYS PLC | 11/12/2025 | 93.83 K | $815.37 K | -16.06% | 0.17% |
| DECHENG CAPITAL LLC | 11/14/2025 | 92.75 K | $805.98 K | -61.28% | 0.17% |
| BNP PARIBAS ARBITRAGE, SNC | 11/13/2025 | 89.62 K | $778.83 K | 40.23% | 0.16% |
| TREXQUANT INVESTMENT LP | 11/14/2025 | 81.35 K | $706.97 K | 100.00% | 0.15% |
| AMERICAN CENTURY COMPANIES INC | 11/12/2025 | 69.62 K | $604.99 K | 42.63% | 0.12% |
| FMR LLC | 11/13/2025 | 65.57 K | $569.80 K | 5.65% | 0.12% |
| ALLIANCEBERNSTEIN L.P. | 11/14/2025 | 65.29 K | $567.37 K | 0.00% | 0.12% |
| RHUMBLINE ADVISERS | 11/06/2025 | 64.18 K | $557.71 K | -2.70% | 0.11% |
| DIMENSIONAL FUND ADVISORS LP | 11/12/2025 | 58.01 K | $503.52 K | 3.70% | 0.10% |
| ACADIAN ASSET MANAGEMENT LLC | 11/13/2025 | 55.10 K | $478.00 K | -83.33% | 0.10% |
| BRIDGEWAY CAPITAL MANAGEMENT, LLC | 11/14/2025 | 50.00 K | $434.50 K | 100.00% | 0.09% |
Explore Related Stocks for Market Trends
Explore our related stocks for the latest market trends and stock news to stay informed and make better decisions.
4D Molecular Therapeutics, Inc. institutional Ownership - FAQ's
During the previous two years, 161 institutional investors and hedge funds held shares of 4D Molecular Therapeutics, Inc.. The most heavily invested institutionals were:
BVF INC/IL: 4.63 M
RA CAPITAL MANAGEMENT, L.P.: 4.56 M
GOLDMAN SACHS GROUP INC: 4.13 M
BlackRock, Inc.: 3.87 M
VANGUARD GROUP INC: 2.58 M
Novo Holdings A/S: 2 M
70.67% of 4D Molecular Therapeutics, Inc. stock is owned by institutional investors.
Institutional investors have bought a total of 44.68 M shares in the last 24 months. This purchase volume represents approximately $382.04 M in transactions.